Recent news on Refludan

New deals for ProBioGens cell engineering group  -  Apr 25, 2007
In-PharmaTechnologist.com,The product is a biosimilar version of Bayer's Refludan (lepirudin). It also sells biosimilar versions of interferon alfa-2a and pegylated interferon

CEO: Pharmion Has Evolved, Could 'Transform' During '07  -  Jan 10, 2007
BioWorld Online,It markets Innohep (tinzaparin), a low-molecular-weight heparin approved in the US for deep-vein thrombosis, as well as Refludan (lepirudin),

Pharmion Acquires Cabrellis: $59M For Lung Cancer Drug  -  12 Dec 2006
BioWorld Online,It also markets Innohep (tinzaparin), a low-molecular-weight heparin approved in the US for deep-vein thrombosis, and Refludan (lepirudin), an antithrombin

Revised Refludan Prescribing Information  -  Nov 15, 2006
Facts and Comparisons,The FDA has revised the prescribing information for Refludan (lepirudin) to include information for use in patients scheduled for transition to oral

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional